论文部分内容阅读
目的分析慢性肝病患者行无痛胃镜的安全性。方法选取2013年9月—2015年12月洛阳市第六人民医院收治的慢性肝病患者41例为观察组,选取同期非肝病患者40例为对照组,两组患者均行无痛胃镜检查。比较两组患者血压、心率、血氧饱和度、苏醒时间,观察观察组麻醉前后丙氨酸氨基转移酶(ALT)、天冬氨酸转氨酶(AST)、碱性磷酸酶(ALP)、γ-谷氨酰转移酶(GGT)等肝功能指标。结果两组患者血压、心率、血氧饱和度比较,差异无统计学意义(P>0.05)。观察组麻醉苏醒时间长于对照组,差异有统计学意义(P<0.05)。观察组麻醉前后ALT、AST、ALP、GGT比较,差异无统计学意义(P>0.05)。结论慢性肝病患者行无痛胃镜检查不会影响患者的肝功能、血压、心率、血氧饱和度,具有安全性。
Objective To analyze the safety of painless gastroscope in patients with chronic liver disease. Methods Seventy-one patients with chronic liver disease admitted from June 2013 to December 2015 in Luoyang Sixth People’s Hospital were selected as the observation group. Forty patients with non-liver disease in the same period were selected as the control group. Painless gastroscopy was performed in both groups. Blood pressure, heart rate, oxygen saturation and recovery time were compared between two groups before and after treatment. The levels of ALT, AST, ALP, Glutamyl transferase (GGT) and other indicators of liver function. Results There was no significant difference in blood pressure, heart rate and oxygen saturation between the two groups (P> 0.05). The observation group anesthesia recovery time longer than the control group, the difference was statistically significant (P <0.05). The ALT, AST, ALP and GGT in observation group before and after anesthesia showed no significant difference (P> 0.05). Conclusion Painless gastroscopy in patients with chronic liver disease will not affect the patient’s liver function, blood pressure, heart rate, oxygen saturation, with safety.